Biomarqueurs pour la présélection des patients pour la thérapie anti-IGF1R

• 收藏
• 分享

专利权人:

Merck Sharp & Dohme Corp.

发明人:

申请号：

EP10184355.5

公开号：

EP2281841A3

申请日:

2005.11.30

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention provides methods for identifying patients whose cancers are likely to be responsive to IGF1R inhibitory anti-cancer therapy along with methods for treating such patients. Patients identified by a method of the present invention can be treated with any of several known IGF1R inhibitory agents including antibodies, small molecule inhibitors and anti-sense nucleic acids.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/